in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (19 hours ago)
The latest #OpenTox webinar focused on #AOPs current trends and developments, presented by Tatyana Doktorova https://t.co/ZKj5PivfiN
Edelweiss Connect (2 days ago)
RT @barryhardy: Tatyana Doktorova will discuss current trends and developments in Adverse Outcome Pathways as exemplified by case studies (…
Edelweiss Connect (2 weeks ago)
Melanie Fischer, winner of the 2019 3RCC’s 3Rs Award, will present the toxicity test developed to use cultured fish… https://t.co/sDQecx5W2Q
Edelweiss Connect (2 weeks ago)
@EawagResearch researcher Melanie Fischer, winner of the 2019 3RCC’s 3Rs Award, will present the toxicity test deve… https://t.co/KaWTm3ClhT
Edelweiss Connect (2 weeks ago)
Last week's #OpenTox webinar on Trust in cloud-based Safety Assessment #blockchain #cybersecurity #dataintegrity… https://t.co/fHq5zInaEq

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA